Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting xience v stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)

American Journal of Cardiology

Volumn 114, Issue 9, 2014, Pages 1329-1338

  Lee, Joo Myung ^a   Park, Kyung Woo ^a   Han, Jung Kyu ^a   Yang, Han Mo ^a   Kang, Hyun Jae ^a   Koo, Bon Kwon ^a   Bae, Jang Whan ^b   Woo, Sung Il ^c   Park, Jin Sik ^d   Jin, Dong Kyu ^e   Jeon, Dong Woon ^f   Oh, Seok Kyu ^g   Park, Jong Seon ^h   Kim, Doo Il ⁱ   Hyon, Min Su ^j   Jeon, Hui Kyung ^k   Lim, Do Sun ^l   Kim, Myeong Gon ^m   Rha, Seung Woon ⁿ   Her, Sung Ho ^o   Hwang, Jin Yong ^p   Kim, Sanghyun ^q   Choi, Young Jin ^d   Kang, Jin Ho ^r   Moon, Keon Woong ^s   Jang, Yangsoo ^t   Kim, Hyo Soo ^a   more..

^a Seoul National University Hospital   (South Korea)

^b Chungbuk National University   (South Korea)

^c Inha University Hospital   (South Korea)

^d Sejong General Hospital   (South Korea)

^e Soonchunhyang University   (South Korea)

^f National Health Insurance Corporation   (South Korea)

^g Wonkwang University School of Medicine   (South Korea)

^h Yeungnam University Hospital   (South Korea)

ⁱ Inje University College of Medicine   (South Korea)

^j Soonchunhyang University College of Medicine   (South Korea)

^k Uijeongbu St Mary's Hospital   (South Korea)

^l Korea University College of Medicine   (South Korea)

^m Kyung Hee University Hospital   (South Korea)

ⁿ Korea University College of Medicine   (South Korea)

^o Daejeon St Mary's Hospital   (South Korea)

^p Gyeongsang National University   (South Korea)

^q Seoul National University Boramae Hospital   (South Korea)

^r Sungkyunkwan University School of Medicine   (South Korea)

^s The Catholic University of Korea   (South Korea)

^t Yonsei University College of Medicine   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; ZOTAROLIMUS; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DISEASE REGISTRY; DRUG ELUTING CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; KOREA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; STENT COMPLICATION; STENT THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; PROSTHESIS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REGISTER; SOUTH KOREA; SURVIVAL RATE; TIME; TRENDS;

ANTINEOPLASTIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; REPUBLIC OF KOREA; SIROLIMUS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908069051     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.07.065     Document Type: Article

References (17)

1. G.W. Stone, A. Rizvi, K. Sudhir, W. Newman, R.J. Applegate, L.A. Cannon, J.T. Maddux, D.E. Cutlip, C.A. Simonton, P. Sood, D.J. Kereiakes, and S.I. Investigators Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
2. R.A. Byrne, A. Kastrati, S. Massberg, A. Wieczorek, K.L. Laugwitz, M. Hadamitzky, S. Schulz, J. Pache, M. Fusaro, J. Hausleiter, A. Schomig, J. Mehilli Investigators I-T Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial J Am Coll Cardiol 58 2011 1325 1331
3. L.O. Jensen, P. Thayssen, E.H. Christiansen, H.H. Tilsted, M. Maeng, K.N. Hansen, A. Kaltoft, H.S. Hansen, H.E. Botker, L.R. Krusell, J. Ravkilde, M. Madsen, L. Thuesen, J.F. Lassen Investigators SOI 2-Year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial J Am Coll Cardiol 60 2012 1140 1147
4. P.C. Smits, E. Kedhi, K.J. Royaards, K.S. Joesoef, J. Wassing, T.A. Rademaker-Havinga, and E. McFadden 2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE stent in all-comers: a randomized open label trial) J Am Coll Cardiol 58 2011 11 18
5. S. Silber, S. Windecker, P. Vranckx, and P.W. Serruys Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial Lancet 377 2011 1241 1247
6. K. Tandjung, H. Sen, M.K. Lam, M.W. Basalus, J.H. Louwerenburg, M.G. Stoel, K.G. van Houwelingen, F.H. de Man, G.C. Linssen, S.A. Said, M.B. Nienhuis, M.M. Lowik, P.M. Verhorst, J. van der Palen, and C. von Birgelen Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting Resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial J Am Coll Cardiol 61 2013 2406 2416
7. M. Taniwaki, G.G. Stefanini, S. Silber, G. Richardt, P. Vranckx, P.W. Serruys, P.E. Buszman, H. Kelbaek, and S. Windecker Four year clinical outcomes and predictors of repeat revascularization in patients treated with new generation drug-eluting stents in the RESOLUTE all comers randomized trial J Am Coll Cardiol 63 2014 1617 1625
8. K.W. Park, J.M. Lee, S.H. Kang, H.S. Ahn, H.M. Yang, H.Y. Lee, H.J. Kang, B.K. Koo, J. Cho, H.C. Gwon, S.Y. Lee, I.H. Chae, T.J. Youn, J.K. Chae, K.R. Han, C.W. Yu, and H.S. Kim Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective EXCELLENT and RESOLUTE-Korea registries J Am Coll Cardiol 61 2013 536 544
9. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
10. P. Vranckx, D.E. Cutlip, R. Mehran, P.P. Kint, S. Silber, S. Windecker, and P.W. Serruys Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies EuroIntervention 5 2010 871 874
11. X.S. Gu, and P.R. Rosenbaum Comparison of multivariate matching methods: structures, distances, and algorithms J Comput Graphical Stat 2 1993 405 420
12. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, S.M. Hollenberg, U.N. Khot, R.A. Lange, L. Mauri, R. Mehran, I.D. Moussa, D. Mukherjee, B.K. Nallamothu, H.H. Ting American College of Cardiology F American Heart Association Task Force on Practice G Society for Cardiovascular A, Interventions 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
13. J. Daemen, P. Wenaweser, K. Tsuchida, L. Abrecht, S. Vaina, C. Morger, N. Kukreja, P. Juni, G. Sianos, G. Hellige, R.T. van Domburg, O.M. Hess, E. Boersma, B. Meier, S. Windecker, and P.W. Serruys Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
14. A.J. Saltzman, G.W. Stone, B.E. Claessen, A. Narula, S. Leon-Reyes, G. Weisz, B. Brodie, B. Witzenbichler, G. Guagliumi, R. Kornowski, D. Dudek, D.C. Metzger, A.J. Lansky, E. Nikolsky, G.D. Dangas, and R. Mehran Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial JACC Cardiovasc Interv 4 2011 1011 1019
15. S. Silber, P.W. Serruys, M.B. Leon, I.T. Meredith, S. Windecker, F.J. Neumann, J. Belardi, P. Widimsky, J. Massaro, V. Novack, A.C. Yeung, S. Saito, and L. Mauri Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program JACC Cardiovasc Interv 6 2013 357 368
16. K.W. Park, J.M. Lee, S.H. Kang, H.S. Ahn, H.J. Kang, B.K. Koo, J.Y. Rhew, S.H. Hwang, S.Y. Lee, T.S. Kang, C.H. Kwak, B.K. Hong, C.W. Yu, I.W. Seong, T. Ahn, H.C. Lee, S.W. Lim, and H.S. Kim Everolimus-eluting xience v/promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus JACC Cardiovasc Interv 7 2014 471 481
17. G.W. Stone, E. Kedhi, D.J. Kereiakes, H. Parise, M. Fahy, P.W. Serruys, and P.C. Smits Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus Circulation 124 2011 893 900